GAFA
DNA icon

Garton & Associates Financial Advisors’s Ginkgo Bioworks DNA Stock Holding History

Garton & Associates Financial Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75
Closed -$623 – 273
2025
Q4 		$623 Buy
+75
New +$808 ﹤0.01% 1147

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Garton & Associates Financial Advisors's DNA Position: Q1 2026 in Review

Garton & Associates Financial Advisors sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 75 shares — an estimated $623 sold.

Garton & Associates Financial Advisors first reported a position in DNA in Q4 2025 and held it in 1 quarter. The position peaked at $623 in Q4 2025. 175 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Garton & Associates Financial Advisors reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
  • Garton & Associates Financial Advisors sold 75 Ginkgo Bioworks shares in Q1 2026, an estimated $623.
  • Garton & Associates Financial Advisors first reported a position in Ginkgo Bioworks in Q4 2025 and held it in 1 quarter.
  • Garton & Associates Financial Advisors's Ginkgo Bioworks position peaked at $623 in Q4 2025.
  • 175 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Garton & Associates Financial Advisors's 13F filing for Q1 2026, filed 11 May 2026.